| Dr Suprasad M Rao, MD | |
|
710 Birchwood Ave, Ste. 201, Bellingham, WA 98225-1720 | |
| (360) 788-6870 | |
| (360) 788-6872 |
| Full Name | Dr Suprasad M Rao |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 34 Years |
| Location | 710 Birchwood Ave, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467490631 | NPI | - | NPPES |
| 200821450 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 01061494A (Indiana) | Primary |
| 2084N0400X | Psychiatry & Neurology - Neurology | MD60148208 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Baycare Medical Ctr | Green bay, WI | Hospital |
| Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baycare Aurora Llc | 0244130557 | 173 |
| Monument Health Rapid City Hospital, Inc. | 6002729506 | 424 |
News Archive
Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.
It has been demonstrated in recent studies that there is a significant breadth of emerging autoreactivity associated with severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. More specifically, researchers from Emory University have identified a relaxation of peripheral tolerance within early antibody secretion cells that arise in individuals infected with SARS-CoV-2, as important drivers of those responses.
Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 3 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.
It has been demonstrated in recent studies that there is a significant breadth of emerging autoreactivity associated with severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. More specifically, researchers from Emory University have identified a relaxation of peripheral tolerance within early antibody secretion cells that arise in individuals infected with SARS-CoV-2, as important drivers of those responses.
Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 3 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.
It has been demonstrated in recent studies that there is a significant breadth of emerging autoreactivity associated with severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. More specifically, researchers from Emory University have identified a relaxation of peripheral tolerance within early antibody secretion cells that arise in individuals infected with SARS-CoV-2, as important drivers of those responses.
Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 3 days ago
| Entity Name | Mercy Health System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031113000164 |
News Archive
Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.
It has been demonstrated in recent studies that there is a significant breadth of emerging autoreactivity associated with severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. More specifically, researchers from Emory University have identified a relaxation of peripheral tolerance within early antibody secretion cells that arise in individuals infected with SARS-CoV-2, as important drivers of those responses.
Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 3 days ago
| Entity Name | Baycare Aurora Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255387726 PECOS PAC ID: 0244130557 Enrollment ID: O20051012000579 |
News Archive
Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.
It has been demonstrated in recent studies that there is a significant breadth of emerging autoreactivity associated with severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. More specifically, researchers from Emory University have identified a relaxation of peripheral tolerance within early antibody secretion cells that arise in individuals infected with SARS-CoV-2, as important drivers of those responses.
Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suprasad M Rao, MD 808 S Silverwood Rd, Muncie, IN 47304-4073 Ph: (505) 807-1508 | Dr Suprasad M Rao, MD 710 Birchwood Ave, Ste. 201, Bellingham, WA 98225-1720 Ph: (360) 788-6870 |
News Archive
Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.
It has been demonstrated in recent studies that there is a significant breadth of emerging autoreactivity associated with severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. More specifically, researchers from Emory University have identified a relaxation of peripheral tolerance within early antibody secretion cells that arise in individuals infected with SARS-CoV-2, as important drivers of those responses.
Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the quarter ended September 30, 2009 and the repurchase of ordinary shares in a private transaction.
A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL.
› Verified 3 days ago
Mr. Ronald A Remick, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 609 N Shore Dr, Bellingham, WA 98226 Phone: 360-676-6000 Fax: 360-676-6006 | |
Dr. Neelam Kumari Sampley, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1133 Railroad Ave Ste 100, Bellingham, WA 98225 Phone: 916-835-0144 | |
Zachary Alan Webb, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1345 King St, Bellingham, WA 98229 Phone: 360-676-1696 Fax: 360-676-6636 | |
Ario H Hosseini, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1050 Larrabee Ave Ste 104-510, Bellingham, WA 98225 Phone: 360-200-8962 | |
Dr. Andrew Denzil Pauli, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1116 Key St Ste 200, Bellingham, WA 98225 Phone: 360-671-1369 Fax: 360-671-0981 | |
Danielle L Kizer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Attn:behavioral Health Services, Bellingham, WA 98225 Phone: 360-788-6993 Fax: 360-715-6996 | |
Dr. James M Harle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1112 11th Street, 301, Bellingham, WA 98225 Phone: 360-414-2222 Fax: 360-414-2220 |